Finance

Lists
PPBT:NASDAQ
Purple Biotech Ltd - ADR
1,46 USD
-0,68%
(-0,0100) 1D
7-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PPBT...
Open
1,44 USD
High
1,48 USD
Low
1,40 USD
Mkt. cap
10,58 млн
Avg. vol.
2,66 млн
Volume
12,87 миң
52-wk high
14,10 USD
52-wk low
1,16 USD
EPS
-28,00 USD
Beta
0,73
Shares outstanding
1,62 млн
No. of employees
10
Open
1,44 USD
High
1,48 USD
Low
1,40 USD
Mkt. cap
10,58 млн
Avg. vol.
2,66 млн
Volume
12,87 миң
52-wk high
14,10 USD
52-wk low
1,16 USD
EPS
-28,00 USD
Beta
0,73
Shares outstanding
1,62 млн
No. of employees
10
News stories
From web sources and news partners
About Purple Biotech Ltd - ADR
CEO-
Employees10
Founded1968
Headquarters-
SectorPharmaceutical industry
Analyst ratings
Based on 1 analyst giving stock ratings to PPBT in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for PPBT in the last 3 months
Highest
Current 1,46 USD
17,00 USD (+1 064,38%)
Average
17,00 USD (+1 064,38%)
Lowest
17,00 USD (+1 064,38%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Maintained
17,00 USD
+1 064,4%
09/21/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
59,00 миң
-
-
Cost of revenue
-
59,00 миң
-
-
Research and development expenses
587,00 миң
1,83 млн
1,23 млн
702,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
780,00 миң
1,08 млн
1,02 млн
597,00 миң
Operating expense
1,37 млн
2,90 млн
2,25 млн
1,30 млн
Total operating expenses
1,37 млн
2,96 млн
2,25 млн
1,30 млн
Operating income
-1,37 млн
-2,96 млн
-2,25 млн
-1,30 млн
Other non operating income
-56,00 миң
-223,00 миң
2,17 млн
1,67 млн
EBT including unusual items
-1,30 млн
-23,64 млн
-89,00 миң
441,00 миң
EBT excluding unusual items
-1,30 млн
-3,16 млн
-89,00 миң
441,00 миң
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,30 млн
-23,54 млн
-86,00 миң
441,00 миң
Net profit margin
-
-
-
-
Earnings per share
2,90
-6,16
-2,33
-0,41
Interest and investment income
123,00 миң
16,00 миң
20,00 миң
79,00 миң
Interest expense
-5,00 миң
-1,00 миң
-31,00 миң
-9,00 миң
Net interest expenses
118,00 миң
15,00 миң
-11,00 миң
70,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,31 млн
-2,91 млн
-2,19 млн
-1,23 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору